Followers | 689 |
Posts | 143817 |
Boards Moderated | 35 |
Alias Born | 03/10/2004 |
Friday, September 13, 2019 7:15:40 AM
By: TheStreet | September 12, 2019
Analysts at Deutsche Bank call the company its 'top pick' in the managed care, drug supply and beneficiary technology space.
CVS Health (CVS - Get Report) shares traded higher Thursday after analysts at Deutsche Bank called the company its "top pick" in the managed care, drug supply and beneficiary technology space, citing the potential for better-than-expected results from its pharmacy services business.
Deutsche Bank initiated coverage with a "buy" rating and a $91 price target, the bank said, but noted upside potential in the $114 range even amid concerns for changes to broader U.S. healthcare regulation, prescription drug pricing reform and pressure on reimbursements from its retail pharmacy business.
"We see the company as well positioned to deliver on a vertical integration care delivery strategy, allowing the company to take share and generate positive earnings surprise," Deutsche Bank said. "We also see the valuation of CVS shares as highly compelling and capturing potential execution and integration risks."
CVS shares were up 0.61% to $64.38 in trading Thursday.
Deutsche Bank also downplayed the impact of Amazon Inc.s (AMZN - Get Report) move into the healthcare business, but cautioned that stocks in the sector may still lag the broader market as lawmakers at the state and federal level continue to challenge the Affordable Care Act.
"While investors spent the last few years worried about the disruptive risks presented by Amazon and other tech companies, the focus has now shifted to Washington DC amid fears of dramatic healthcare reform," the bank said. "However, we believe the potential for substantive reform is remote - Republicans seem most likely to maintain control of the Senate, frustrating any initiatives by Democrats."
Last month, CVS posted stronger-than-expected second quarter earnings Wednesday, and boosted its full-year profit guidance as it continues to integrate last year's $69 billion purchase of health insurer Aetna.
CVS said adjusted earnings for the June quarter rose 12% to $1.89 per share as group reveues surged 35.2% from last year to $63.4 billion ,topping analysts' forecasts of a $62.66 billion tally, as Aetna sales added to the company' topline growth.
Looking into 2019, CVS narrowed and raised its full-year earnings forecast to a range of $6.89 to $7.00 per share, up from a prior estimate of $6.75 to $6.90.
Read Full Story »»»
• DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Your Due Dilegence is a must!
• DiscoverGold
Recent CVS News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2024 09:29:08 PM
- CVS Health announces quarterly dividend • PR Newswire (US) • 09/19/2024 03:02:00 PM
- CVS Pharmacy® launches birth control prescribing in Massachusetts • PR Newswire (US) • 09/12/2024 01:00:00 PM
- CVS Health supporting customers, patients, members and colleagues as Tropical Storm Francine approaches • PR Newswire (US) • 09/10/2024 07:43:00 PM
- Shareholders of CVS Health Corporation Should Contact The Gross Law Firm Before September 10, 2024 to Discuss Your Rights - CVS • PR Newswire (US) • 09/09/2024 02:32:00 PM
- The Gross Law Firm Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CVS • PR Newswire (US) • 09/05/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 09:47:27 PM
- CVS Health Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CVS • PR Newswire (US) • 08/29/2024 10:05:00 AM
- Updated flu and COVID-19 vaccinations now available at CVS Pharmacy® and MinuteClinic® • PR Newswire (US) • 08/28/2024 12:00:00 PM
- Aetna first major insurer to expand and simplify access to fertility services • PR Newswire (US) • 08/27/2024 12:00:00 PM
- Class Action Filed Against CVS Health Corporation (CVS) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/26/2024 09:45:00 AM
- Shareholders of CVS Health Corporation Should Contact The Gross Law Firm Before September 10, 2024 to Discuss Your Rights - CVS • PR Newswire (US) • 08/22/2024 09:45:00 AM
- CVS Pharmacy® introduces colleague-designed journals • PR Newswire (US) • 08/21/2024 12:00:00 PM
- CVS Health Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 10, 2024 to Discuss Your Rights - CVS • PR Newswire (US) • 08/19/2024 09:45:00 AM
- Google Mandated to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova • IH Market News • 08/15/2024 10:05:46 AM
- Google Forced to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova • IH Market News • 08/15/2024 10:05:46 AM
- CVS Health Corporation Class Action: The Gross Law Firm Reminds CVS Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 10, 2024 - CVS • PR Newswire (US) • 08/15/2024 09:45:00 AM
- CVS Health Names Heidi Capozzi Executive Vice President, Chief People Officer • PR Newswire (US) • 08/14/2024 08:00:00 PM
- CVS Health Foundation joins forces with organizations at City Center to improve health outcomes in Fresno • PR Newswire (US) • 08/14/2024 05:00:00 PM
- AM Best Revises Issuer Credit Rating Outlooks to Stable for Most of CVS Health Corporation’s Aetna Inc. Subsidiaries • Business Wire • 08/14/2024 02:39:00 PM
- Class Action Filed Against CVS Health Corporation (CVS) - September 10, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:35:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:33:48 AM
- CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE • PR Newswire (US) • 08/07/2024 10:30:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM